PARG inhibition induces nuclear aggregation of PARylated PARP1

Sateja Paradkar1, Julia Purcell2, Annie Cui2

  • 1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510-8034, USA; Department of Pathology, Yale University School of Medicine, New Haven, CT 06510-8034, USA.

PubMed

Insights

Poly (ADP-ribose) glycohydrolase (PARG) inhibitors cause poly (ADP-ribose) polymerase 1 (PARP1) mislocalization and aggregation. This unexpected mechanism of PARG inhibitor cytotoxicity reveals new insights into their use as anti-cancer therapeutics.

Area of Science:

  • Molecular Biology
  • Cancer Therapeutics
  • Biochemistry

Background:

  • Poly (ADP-ribose) glycohydrolase (PARG) inhibitors are investigated for DNA repair-deficient cancers.
  • The exact mechanism of action for PARG inhibitors remains unclear.

Purpose of the Study:

  • To elucidate the mechanism of action of PARG inhibitors.
  • To understand the cytotoxicity of PARG inhibitors in cancer treatment.

Main Methods:

  • Investigated the effect of PARG inhibition on poly (ADP-ribose) polymerase 1 (PARP1) localization.
  • Analyzed PARP1 aggregation and its dependence on catalytic activity.
  • Examined the persistence of PARP1 aggregates and their association with cell death.

Main Results:

  • PARG inhibition results in excessive PARylation of PARP1, impairing its localization to DNA damage sites.
  • Mis-localized PARP1 forms nuclear aggregates, dependent on PAR chains.
  • PARP1 aggregates are persistent and linked to cleaved PARP1 in the cytoplasm, leading to cell death.

Conclusions:

  • PARG inhibitors induce cytotoxicity through a novel mechanism involving PARP1 mislocalization and aggregation.
  • This finding provides critical insights for the development of PARG inhibitors as anti-cancer drugs.

Related Concept Videos

Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K